Additional information
White powder
1402053-59-1
ACI-036414
145.9-148.8°C
C14H20N2O4
280.32
Ambient
2-8°C
Neurodegenerative
Pharmaceutical Impurity Standards
(S)-methyl 2-(2-(propan-2-ylidene)hydrazinyl)-2-(3,4-dihydroxybenzyl)propanoate
(S)-methyl 2-(2-(propan-2-ylidene)hydrazinyl)-2-(3,4-dihydroxybenzyl)propanoate
Benzenepropanoic acid, 3,4-dihydroxy-?-methyl-?-[2-(1-methylethyl)diazenyl]-, methyl ester, (?S)





![BUTOXYQUINOLINONE BREXPIPRAZOLE (25 mg) (7-[4-(7-{4-[4-(Benzo[b]thiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2-yloxy)butoxy]quinolin-2(1H)-one)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)